exRNAdisease

Entry Detail

---



General Information

Database ID: exR0359354 RNA Name: ACVR2B RNA Type: mRNA Chromosome: chr3 Starnd: + Coordinate: Start Site(bp): 38453890 End Site(bp): 38493142 External Links: ENSG00000114739

Disease Information

Disease Name: Amyotrophic Lateral Sclerosis Disease Category: Nervous System Diseases MeSH ID: D000690 Type: Diseases Category/Nervous System Diseases Alias: Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis

Expression Detail

GEO ID: GSE121519 Description: Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. Experimental Design: Disease vs Control Case Disease Type: Amyotrophic Lateral Sclerosis Case Disease SubType: NA Case Sample: Amyotrophic Lateral Sclerosis Control Sample: Healthy Number of Case: 4 Number of Control: 4 Number of Samples: 8

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand SF3A3 chr1 37956975 37990075 - LSM4 chr19 18306230 18323274 - DDX17 chr22 38483438 38507660 - MTCH1 chr6 36968141 36986298 - BCL6 chr3 187721377 187745725 - TCOF1 chr5 150357629 150400308 + LZTS2 chr10 100996618 101007836 + PACSIN2 chr22 42835412 43015149 - CBY1 chr22 38656636 38673854 + ZDBF2 chr2 206274663 206314427 + UNC45A chr15 90930180 90954093 + FAM111B chr11 59107185 59127412 + UBE3B chr12 109477402 109536705 + DNAAF2 chr14 49625174 49635230 - GPAM chr10 112149865 112215377 - CHRFAM7A chr15 30357766 30393849 - SORD chr15 45023181 45077185 + HSPA5 chr9 125234853 125241343 - MT-CO3 chrMT 9207 9990 + TBC1D15 chr12 71839707 71927248 + MYO7A chr11 77128246 77215241 + TUBA1B chr12 49127782 49131397 - HNRNPAB chr5 178204533 178211163 + MRPL12 chr17 81703367 81707517 + SNRPN chr15 24823637 24978723 + AL138752.2 chr9 37588413 38068687 - NT5DC2 chr3 52524385 52535054 - ISOC1 chr5 129094749 129114028 + SLC25A17 chr22 40769630 40819399 - CRMP1 chr4 5748084 5893086 - miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-221-3p chrX 45746180 45746202 - hsa-miR-423-5p chr17 30117095 30117117 + circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC090948.2 chr3 16339308 16339871 + AD000090.1 chr19 35557956 35581954 + LINC01578 chr15 92819540 92899701 + LINC02035 chr3 122886941 122892416 + NEAT1 chr11 65422774 65445540 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE121519 Sample Source: Cerebrospinal Fluid Source Fraction: Exosome Platform: GPL18573 Method: NGS Num of detected RNA Type: 2 Num of detected RNAs of this Type: 17787 Sample treatment protocol: Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant. RNA Extract protocol: Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted. RNA library preparation protocol: Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.

Reference

PMID: 30630471 Title: Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid Author: Otake K, Kamiguchi H, Hirozane Y Journal: BMC Med Genomics. 2019 Jan 10;12(1):7. Description: The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.